B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $6
B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $6
B. Riley Securities维持对Journey Medical的买入，将目标股价提高
B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $3 to $6.
B. Riley Securities分析师卡尔皮特·帕特尔维持Journey Medical（纳斯达克股票代码：DERM）的买入，并将目标股价从3美元上调至6美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。